BG
CLVS
Bellevue Group’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-71,200
| Closed | -$453K | – | 228 |
|
|
2020
Q1 | $453K | Sell |
71,200
-1,700
| -2% | -$10.8K | 0.01% | 165 |
|
|
2019
Q4 | $760K | Buy |
+72,900
| New | +$760K | 0.01% | 154 |
|
|
2018
Q3 | – | Sell |
-17,250
| Closed | -$784K | – | 145 |
|
|
2018
Q2 | $784K | Sell |
17,250
-500
| -3% | -$22.7K | 0.07% | 124 |
|
|
2018
Q1 | $937K | Sell |
17,750
-250
| -1% | -$13.2K | 0.09% | 107 |
|
|
2017
Q4 | $1.22M | Sell |
18,000
-500
| -3% | -$34K | 0.13% | 104 |
|
|
2017
Q3 | $1.52M | Hold |
18,500
| – | – | 0.16% | 93 |
|
|
2017
Q2 | $1.73M | Hold |
18,500
| – | – | 0.2% | 85 |
|
|
2017
Q1 | $1.18M | Sell |
18,500
-1,500
| -8% | -$95.5K | 0.16% | 96 |
|
|
2016
Q4 | $888K | Sell |
20,000
-23,000
| -53% | -$1.02M | 0.18% | 92 |
|
|
2016
Q3 | $1.55M | Buy |
+43,000
| New | +$1.55M | 0.28% | 83 |
|
|
2016
Q2 | – | Sell |
-52,500
| Closed | -$1.01M | – | 134 |
|
|
2016
Q1 | $1.01M | Buy |
+52,500
| New | +$1.01M | 0.18% | 96 |
|